In conclusion, high Granzyme-B+PD-1+ T cell responses to <i>M. tuberculosis</i> and, possibly, of CD8+GMM+Granzyme-B+ T cells may be desirable for new TB vaccines. This evidence concerns the gene CD8A and tuberculosis.